Bigfoot Biomedical Overview
- Year Founded
-
2014

- Status
-
Acquired/Merged
- Employees
-
144

- Latest Deal Type
-
M&A
Bigfoot Biomedical General Information
Description
Developer of a diabetes management system designed to reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes. The company's system optimizes the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secured and user-friendly consumer technologies, enabling patients to live healthy lives with better diabetes disease management.
Contact Information
Website
www.bigfootbiomedical.com
Formerly Known As
SmartLoop Labs
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Monitoring Equipment
Parent Company
Primary Office
- 1820 McCarthy Boulevard
- Milpitas, CA 95035
- United States
+1 (408) 000-0000
Bigfoot Biomedical Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Merger/Acquisition | 22-Sep-2023 | 00000 | Completed | Generating Revenue | ||
6. Later Stage VC | 01-Nov-2022 | 00000 | Completed | Generating Revenue | ||
5. Later Stage VC | 17-Mar-2021 | 00000 | Completed | Generating Revenue | ||
4. Later Stage VC (Series C) | 02-Jun-2020 | 0000 | 00000 | Completed | Generating Revenue | |
3. Early Stage VC (Series B) | 28-Mar-2018 | 0000 | 0000 | 00000 | Completed | Generating Revenue |
2. Early Stage VC (Series A) | 19-Oct-2016 | $36M | $38M | 0000 | Completed | Startup |
1. Seed Round | 01-Dec-2014 | $2M | $2M | 00.00 | Completed | Startup |
Bigfoot Biomedical Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Junior 2 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
Series A | 6,558,722 | $0.000100 | $0.44 | $5.55 | $5.55 | 1x | $5.55 | 36.69% |
Junior Pref | 2,000,000 | $0.000100 | $1 | $1 | $1 | 11.48% |
Bigfoot Biomedical Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of a diabetes management system designed to reduce the cognitive, emotional, and financial burden of insulin-r
Monitoring Equipment
Milpitas, CA
144
As of 2023
00000
000000&0
00000
Bigfoot Biomedical Competitors (11)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Senseonics | Formerly VC-backed | Germantown, MD | 000 | 00000 | 000000000 | 00000 |
0000000 | Venture Capital-Backed | San Diego, CA | 00 | 000.00 | 00000000000 | 000.00 |
0000 000000000 | Private Equity-Backed | Fremont, CA | 00 | 00000 | 000000000 | 00000 |
00000000 | Private Equity-Backed | Malvern, PA | 0000 | 00000 | 0000000 0000 | 00000 |
0000 0000000 | Venture Capital-Backed | Irvine, CA | 000 | 00000 | 00000000000 | 00000 |
Bigfoot Biomedical Patents
Bigfoot Biomedical Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220339367-A1 | Insulin delivery and data collection systems, insulin therapy management system, and related methods | Pending | 26-Apr-2021 | 000000000 | |
EP-4272219-A1 | Visualizing outcomes of applying recommended insulin therapy settings, and related systems and devices | Pending | 31-Dec-2020 | 000000000 | |
US-20220208330-A1 | Visualizing outcomes of applying recommended insulin therapy settings, and related systems and devices | Pending | 31-Dec-2020 | 000000000 | |
US-20220105282-A1 | Injection site determination systems and methods for injection site tracking and recommending injection sites | Pending | 02-Oct-2020 | 000000000 | |
EP-4222757-A1 | Injection site determination systems and methods for injection site tracking and recommending injection sites | Pending | 02-Oct-2020 | G16H20/17 |
Bigfoot Biomedical Executive Team (14)
Bigfoot Biomedical Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
Bryan Mazlish | Self | Co-Founder & Executive Board Member | 000 0000 |
Bigfoot Biomedical Signals
Bigfoot Biomedical Former Investors (21)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Abbott Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
Agrocorp Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Ali Partovi | Angel (individual) | Minority | 000 0000 | 000000 0 | |
Brett Campbell | Angel (individual) | Minority | 000 0000 | 000000 0 | |
Cormorant Asset Management | Hedge Fund | Minority | 000 0000 | 000000 0 |
Bigfoot Biomedical Acquisitions (3)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Common Sensing | 14-Jun-2021 | 0000000000 | Monitoring Equipment | 0000000 0 | |
Timesulin | 08-Jun-2017 | 0000000000 | Monitoring Equipment | 0000000 0 | |
Asante Solutions | 28-May-2015 | Merger/Acquisition | Therapeutic Devices | 0000000 0 |
Bigfoot Biomedical Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
Timesulin | Monitoring Equipment | London, United Kingdom | 0000 |